Home > Insider Trading > Onyx Pharmaceuticals Inc

Onyx Pharmaceuticals Inc (ONXX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

An Excellent Investment in the Biotech Space?

According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected to die from the disease in 2013. Limited treatment...

Keep Reading →

September 23rd, 2013 - News

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): Revelations From This Blazing Biotech

With all of the heat generated by this biotech and its stock, it pays to pay attention to what Celgene Corporation (NASDAQ:CELG) says.

Keep Reading →

September 16th, 2013 - News

Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?

At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.

Keep Reading →

September 10th, 2013 - News

Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)

As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, Inc.

Keep Reading →

September 9th, 2013 - News

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): When Will the Good News End for This Biotech?

The big biotech announced on Thursday that updated results from its phase 3 study of Pomalyst in treating relapsed or refractory multiple myeloma had been published online in The Lancet Oncology ahead...

Keep Reading →

September 5th, 2013 - News

Astex Pharmaceuticals, Inc. (ASTX) Becomes the Latest Biotech Domino to Fall

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) is being scooped up by Tokyo-based Otsuka Pharmaceuticals.

Keep Reading →

September 5th, 2013 - News

Pharma News Highlights: VIVUS, Inc. (VVUS) New CEO, Arena Pharmaceuticals, Inc. (ARNA)'s Rating, Amgen, Inc. (AMGN)'s Acquisition

VIVUS, Inc.

Keep Reading →

September 5th, 2013 - News

Amgen, Inc. (AMGN), Astex Pharmaceuticals, Inc. (ASTX), Pharmacyclics, Inc. (PCYC): This Week in Biotech

With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

September 1st, 2013 - News

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Monday's Best Stocks

For the fourth-straight week it appears that the broad-based S&P 500 (SNPINDEX:^GSPC) is starting off on shaky ground. The culprits today appear to be weak U.S.

Keep Reading →

August 27th, 2013 - News

Amgen, Inc. (AMGN), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Onyx Pharmaceuticals, Inc. (ONXX): This Biotech Envisions Green

After a second offer, Amgen, Inc. (NASDAQ:AMGN) and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX), a maker of drugs to fight cancer among other diseases, are in agreement on the offer price.

Keep Reading →

August 27th, 2013 - News